Yahoo Finance

Interleukin-13 Inhibitors Market Predicted to Surge During the Forecast Period (2025-2034) Due to Breakthrough Therapies in Atopic Dermatitis, Asthma, CRSwNP, and Others ...

DelveInsight's Interleukin-13 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, ...
Healio

FDA approves targeted interleukin-13 inhibitor for moderate-to-severe atopic dermatitis

Please provide your email address to receive an email when new articles are posted on . Ebglyss is a targeted interleukin-13 inhibitor approved for the treatment of moderate-to-severe atopic ...
Nature

Gene transfer of interleukin 13 receptor α2 chain dramatically enhances the antitumor effect of IL-13 receptor–targeted cytotoxin in human prostate cancer xenografts

Vitetta ES, Fulton RJ, May RD, Till M, Uhr JM . Redesigning nature's poisons to create antitumor reagents Science 1988 238: 1098–1101 ...
FierceBiotech

Receptos Licenses Anti-Interleukin-13 Antibody From AbbVie For Phase 2 Development In Orphan Disease

SAN DIEGO, March 13, 2013 /PRNewswire/ – Receptos Inc. announced today that it has entered a Development License and Option Agreement to in-license a humanized anti-interleukin-13 (IL-13) antibody ...